Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050622 · ClinicalTrials.gov registry record · NA
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
- 2
- Study locations
NCT00050622: Completed NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Florida International University.
NCT00050622 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Florida International University. The registered enrollment target is 154 participants, below the 347-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00050622, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.
Primary Outcome
Sum of daily frequency of Verbal Abuse toward staff members, Teasing toward peers, and Cursing/Swearing as defined by a behavioral point system that doubles as an objective measure of children's behavior. All instances of these behaviors were reported and noted as they occur throughout daily activities.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Methylphenidate 0.15 mg/kg
- BEHAVIORAL Low-Intensity BMOD
- DRUG Methylphenidate 0.3 mg/kg
- DRUG Methylphenidate 0.6 mg/kg
Study Locations (2)
Florida
- Florida International University Center for Children and Families - Miami
New York
- Center for Children and Families, University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2001-09 |
| Est. Completion | 2005-06 |
| Phase | NA |
What the finished NCT00050622 record still lists
NCT00050622 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 347-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT00050622 reports a single indexed study location in Florida, New York.
Frequently Asked Questions
What is clinical trial NCT00050622 about?
NCT00050622 is a clinical study titled "Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)". The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.
What is the current status of trial NCT00050622?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2001-09. Estimated completion is 2005-06.
What conditions does trial NCT00050622 study?
This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.
What interventions are being tested in trial NCT00050622?
The interventions under investigation include: Placebo (DRUG), Methylphenidate 0.15 mg/kg (DRUG), Low-Intensity BMOD (BEHAVIORAL), Methylphenidate 0.3 mg/kg (DRUG), Methylphenidate 0.6 mg/kg (DRUG).
Who is sponsoring clinical trial NCT00050622?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00050622 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Disorder With Hyperactivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00050622's enrollment target sits among peer trials
154 9th of 20 higher than 12 of 20 other Attention Deficit Disorder With Hyperactivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention Deficit Disorder With Hyperactivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
RECRUITING · NA
-
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD
COMPLETED · NA
-
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
COMPLETED · NA
-
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia